Ignite Creation Date:
2025-12-24 @ 5:42 PM
Ignite Modification Date:
2026-01-02 @ 8:15 AM
Study NCT ID:
NCT02597868
Status:
UNKNOWN
Last Update Posted:
2016-03-29
First Post:
2014-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)
Sponsor:
Zhejiang Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01
Start Date Type:
None
Primary Completion Date:
2016-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-07
Completion Date Type:
ESTIMATED
First Submit Date:
2014-03-09
First Submit QC Date:
None
Study First Post Date:
2015-11-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-26
Last Update Post Date:
2016-03-29
Last Update Post Date Type:
ESTIMATED